Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that Vivanta Industries Limited has entered into certain business collaboration agreements with Qness Pharmaceuticals a proprietorship concern in connection with the manufacture supply branding and marketing of pharmaceutical and allied products.